526 related articles for article (PubMed ID: 22310282)
1. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
3. EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.
Nakada M; Niska JA; Tran NL; McDonough WS; Berens ME
Am J Pathol; 2005 Aug; 167(2):565-76. PubMed ID: 16049340
[TBL] [Abstract][Full Text] [Related]
4. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells.
Nakada M; Niska JA; Miyamori H; McDonough WS; Wu J; Sato H; Berens ME
Cancer Res; 2004 May; 64(9):3179-85. PubMed ID: 15126357
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CPNE3 suppresses invasion, migration and proliferation of glioblastoma cells through FAK pathway inactivation.
Shi D; Lin B; Lai J; Li K; Feng Y
J Mol Histol; 2021 Jun; 52(3):589-596. PubMed ID: 33725213
[TBL] [Abstract][Full Text] [Related]
6. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling.
Jiang K; Yao G; Hu L; Yan Y; Liu J; Shi J; Chang Y; Zhang Y; Liang D; Shen D; Zhang G; Meng S; Piao H
Cell Death Dis; 2020 Apr; 11(4):230. PubMed ID: 32286266
[TBL] [Abstract][Full Text] [Related]
7. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
8. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL
Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells.
Bello-Alvarez C; Moral-Morales AD; González-Arenas A; Camacho-Arroyo I
Front Endocrinol (Lausanne); 2021; 12():640298. PubMed ID: 33841333
[TBL] [Abstract][Full Text] [Related]
11. O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.
Chahal M; Abdulkarim B; Xu Y; Guiot MC; Easaw JC; Stifani N; Sabri S
Mol Cancer Ther; 2012 Nov; 11(11):2440-50. PubMed ID: 22986464
[TBL] [Abstract][Full Text] [Related]
12. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.
Hayashi K; Michiue H; Yamada H; Takata K; Nakayama H; Wei FY; Fujimura A; Tazawa H; Asai A; Ogo N; Miyachi H; Nishiki T; Tomizawa K; Takei K; Matsui H
Sci Rep; 2016 Mar; 6():23372. PubMed ID: 26988603
[TBL] [Abstract][Full Text] [Related]
14. Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho kinases-1 and metalloproteinase-9.
Lin CC; Chen JT; Yang JS; Lu HF; Hsu SC; Tan TW; Lin YT; Ma YS; Ip SW; Wu JJ; Li YC; Chung JG
Oncol Rep; 2009 Nov; 22(5):1033-7. PubMed ID: 19787217
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Sun P; Xia S; Lal B; Shi X; Yang KS; Watkins PA; Laterra J
BMC Cancer; 2014 Jun; 14():401. PubMed ID: 24893952
[TBL] [Abstract][Full Text] [Related]
16. PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex.
de Semir D; Bezrookove V; Nosrati M; Scanlon KR; Singer E; Judkins J; Rieken C; Wu C; Shen J; Schmudermayer C; Dar AA; Miller JR; Cobbs C; Yount G; Desprez PY; Debs RJ; Salomonis N; McAllister S; Cleaver JE; Soroceanu L; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9064-9073. PubMed ID: 32273388
[TBL] [Abstract][Full Text] [Related]
17. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
[TBL] [Abstract][Full Text] [Related]
19. Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology.
Rogers AE; Le JP; Sather S; Pernu BM; Graham DK; Pierce AM; Keating AK
Oncogene; 2012 Sep; 31(38):4171-81. PubMed ID: 22179835
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells.
Weber GL; Parat MO; Binder ZA; Gallia GL; Riggins GJ
Oncotarget; 2011 Nov; 2(11):833-49. PubMed ID: 22064833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
